Brief: BiomX Reports Topline Results Of Phase 2 Cosmetic Acne Study

Biomx

18/10/2021 14:42

Oct 18 (Reuters) - Biomx Inc  PHGE.A :
    * BIOMX REPORTS TOPLINE RESULTS OF PHASE 2 COSMETIC ACNE
STUDY
    * BIOMX INC - 12-WEEK STUDY OF BX001 MEETS SAFETY AND
TOLERABILITY
ENDPOINTS
    * BIOMX INC - STATISTICALLY SIGNIFICANT IMPROVEMENT FROM
BASELINE
OBSERVED IN APPEARANCE OF ACNE-PRONE SKIN
    * BIOMX INC - NO MEANINGFUL DIFFERENCE DEMONSTRATED RELATIVE
TO
VEHICLE
    * BIOMX INC - SUBJECT SATISFACTION QUESTIONNAIRE OUTCOMES
INDICATE
PREFERENCE FOR BX001 OVER VEHICLE ON KEY PARAMETERS
    * BIOMX INC - BX001 WAS DEMONSTRATED TO BE SAFE AND
WELL-TOLERATED

Source text for Eikon:  ID:nGNX94SbVP 
Further company coverage:  PHGE.A 

 ((reuters.briefs@thomsonreuters.com;))